NCT04962022 - Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions

Healthy Participant

Interventions

DRUG

PF-07321332/ritonavir

Administered orally every 12 hours for days for a total of 5 doses from Day 1 through Day 3

DRUG

Itraconazole

Administered orally once daily for 8 days from Days 1 through 8

DRUG

PF-07321332/ritonavir

Administered orally BID for 3 day for a total on 5 doses starting on Day 4 through Day 6

Trial Locations (1)

Brussels Clinical Research Unit, Brussels